The Only Public Space Stock Even Elon Musk Can’t Dismiss

Here’s the uncomfortable truth for anyone who wants exposure to the space economy: the company that dominates it isn’t public. SpaceX prints launches, prints Starlink revenue, and prints headlines. You can’t buy it. So when SpaceX itself bothers to name the rivals it actually watches, that list matters. The names cited include United Launch Alliance, Arianespace, Northrop Grumman (NYSE:NOC | NOC Price Prediction), Blue Origin, Firefly Aerospace, Relativity Space, and Rocket Lab. Of that group, exactly one is a tradable pure-play. That’s the trade.

Rocket Lab: The Only Public Pure-Play

Rocket Lab (NASDAQ:RKLB) is described by SpaceX as a company that “operates in the small-lift launch market but is expanding into medium-lift payloads.” Translation: small rockets today, Falcon 9 territory tomorrow. I’ve been tracking this name since the SPAC days, and the story has finally caught up to the ambition. Shares are up 424% over the past year, and the market cap now sits around $83 billion.

The Small-Lift Cash Engine

Electron is already the workhorse. “We’ve got more than 70 launches in backlog now, which is a new record,” CEO Peter Beck said on the Q1 call. HASTE, the hypersonic variant, now represents almost one-third of all launch backlog, riding a wave of Department of War spending that includes a $190 million 20-launch MACH-TB order.

Neutron: The SpaceX-Tier Bet

Medium-lift is where this gets interesting. Neutron debuts later in 2026, and Beck just announced “the largest contract in Rocket Lab’s history: five dedicated Neutron flights plus three Electrons” for a confidential customer. He added: “Of all of the things that I sit awake at night worrying about, Neutron demand is just not one of them.”

The Numbers Behind the Thesis

Q1 revenue hit $200.3 million, up 63.5% year over year, with non-GAAP gross margin expanding to 43%. Backlog stands at $2.2 billion, and the company has more than $2 billion in liquidity. Add the $816 million Space Development Agency Tracking Layer Tranche 3 contract and selection for Golden Dome’s Space-Based Interceptor program with RTX (NYSE:RTX), and you have a defense prime in the making.

The Risks I’d Underwrite

This isn’t free money. Rocket Lab still posted a $45 million net loss, raised $450 million via ATM offering in Q1, and trades at 122 times sales. Analyst consensus price target sits at $103.91, well below today’s $143.48. Neutron’s first flight has slipped before. Director Alexander Slusky sold 110,000 shares in May at prices between $115 and $120.

The Logic Bridge

You’d want to own Rocket Lab if you believe Neutron flies, Golden Dome funds out, and vertical integration across launch, satellites, and payloads compounds into a second SpaceX-shaped business. If Neutron slips again or defense budgets pivot, the valuation has nowhere to hide. SpaceX named Rocket Lab for a reason. Until Musk’s company files to trade, it’s the only seat at this table you can actually buy.